Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
• Pint Pharma to Make Upfront Investment in Onconova• Onconova also Eligible to Receive up to $42.75 Million in Regulatory and Sales Milestones NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) --...
-
Effect of rigosertib plus azacitidine treatment on epigenetic modulation in cancer cell-lines and patient derived bone marrow cellsStudy suggests potential novel clinical strategies to improve...
-
NEWTOWN, Pa., March 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
-
Exploration of dose and schedule of administration in an expanded Phase 2 trial with the objective of designing a pivotal Phase 3 trialRisk-mitigation strategies to reduce the incidence of urinary...
-
Product stability studies for rigosertib, a Phase 3 clinical stage product in development for Myelodysplastic Syndromes (MDS)Discovery of a novel kinase inhibitor, ON 150030, a Type 1 inhibitor of...
-
NEWTOWN, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small...
-
NEWTOWN, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical company focused on discovering and developing small...
-
NEWTOWN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to...
-
Independent Data Monitoring Committee (DMC) recommends continuation of INSPIRE trial with trial expansion per adaptive design based on interim analysis results for overall survival Trial Executive...
-
Agreement related to study of rigosertib in pediatric RASopathiesClinical trial in pediatric patients to be conducted by the National Cancer InstituteRASopathies are orphan diseases believed to be...